Joachim Marr

1.4k total citations
32 papers, 1.0k citations indexed

About

Joachim Marr is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Joachim Marr has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 13 papers in Reproductive Medicine and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Joachim Marr's work include Reproductive Health and Contraception (20 papers), Menstrual Health and Disorders (10 papers) and Endometriosis Research and Treatment (10 papers). Joachim Marr is often cited by papers focused on Reproductive Health and Contraception (20 papers), Menstrual Health and Disorders (10 papers) and Endometriosis Research and Treatment (10 papers). Joachim Marr collaborates with scholars based in Germany, United States and Finland. Joachim Marr's co-authors include Christoph Gerlinger, Christine Klipping, Christian Seitz, T. Strowitzki, Thomas Faustmann, Dietmar Trummer, Carole Sampson-Landers, Ingrid Duijkers, Michael Kunz and Gloria Bachmann and has published in prestigious journals such as Human Reproduction, Fertility and Sterility and Obstetrics and Gynecology.

In The Last Decade

Joachim Marr

32 papers receiving 973 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joachim Marr Germany	17	631	588	385	115	93	32	1.0k
Fatih Durmuşoğlu Türkiye	17	267 0.4×	423 0.7×	126 0.3×	42 0.4×	32 0.3×	30	805
Begüm Aydoğan Mathyk Türkiye	15	314 0.5×	333 0.6×	177 0.5×	174 1.5×	8 0.1×	64	707
Tjeerd Korver United States	14	722 1.1×	305 0.5×	151 0.4×	237 2.1×	11 0.1×	26	858
PonJola Coney United States	12	278 0.4×	314 0.5×	83 0.2×	95 0.8×	15 0.2×	25	586
C. Marin Deugarte United States	8	436 0.7×	604 1.0×	85 0.2×	202 1.8×	11 0.1×	13	843
N. A. Abdulwahid United States	6	524 0.8×	682 1.2×	106 0.3×	71 0.6×	11 0.1×	8	785
Ingrid Duijkers Netherlands	23	1.0k 1.6×	805 1.4×	195 0.5×	235 2.0×	5 0.1×	50	1.4k
Angela Ferrer Spain	10	337 0.5×	532 0.9×	223 0.6×	376 3.3×	10 0.1×	14	980
D. A. Rodin United Kingdom	9	361 0.6×	466 0.8×	135 0.4×	84 0.7×	6 0.1×	10	681
Hakan Kıran Türkiye	10	164 0.3×	123 0.2×	141 0.4×	82 0.7×	14 0.2×	48	418

Countries citing papers authored by Joachim Marr

Since Specialization

Citations

This map shows the geographic impact of Joachim Marr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Marr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Marr more than expected).

Fields of papers citing papers by Joachim Marr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Marr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Marr. The network helps show where Joachim Marr may publish in the future.

Co-authorship network of co-authors of Joachim Marr

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Marr. A scholar is included among the top collaborators of Joachim Marr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Marr. Joachim Marr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marr, Joachim, et al.. (2015). Efficacy and safety of an oral contraceptive containing ethinylestradiol 20 µg/drospirenone 3 mg (24/4 regimen) in three indications in the People's Republic of China: a comparison with international studies. PubMed. 6. 95–95. 3 indexed citations

Gerlinger, Christoph, James Trussell, Uwe Mellinger, et al.. (2014). Different Pearl Indices in studies of hormonal contraceptives in the United States: impact of study population. Contraception. 90(2). 142–146. 14 indexed citations

Heger-Mahn, Doris, et al.. (2012). Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women. Contraception. 86(1). 28–34. 3 indexed citations

Marr, Joachim, Christoph Gerlinger, & Michael Kunz. (2012). A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen. European Journal of Obstetrics & Gynecology and Reproductive Biology. 162(1). 91–95. 7 indexed citations

Klipping, Christine, et al.. (2012). Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study. Journal of Family Planning and Reproductive Health Care. 38(2). 73–83. 29 indexed citations

Strowitzki, T., Joachim Marr, Christoph Gerlinger, Thomas Faustmann, & Christian Seitz. (2012). Detailed analysis of a randomized, multicenter, comparative trial of dienogest versus leuprolide acetate in endometriosis. International Journal of Gynecology & Obstetrics. 117(3). 228–233. 67 indexed citations

Anttila, Leena, W. Neunteufel, Felice Petraglia, Joachim Marr, & Michael Kunz. (2011). Cycle Control and Bleeding Pattern of a 24/4 Regimen of Drospirenone 3 mg/Ethinylestradiol 20 μg Compared with a 21/7 Regimen of Desogestrel 150 μg/Ethinylestradiol 20 μg. Clinical Drug Investigation. 31(8). 519–525. 7 indexed citations

Koltun, William, Jennifer Maloney, Joachim Marr, & Michael Kunz. (2011). Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a pooled analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 155(2). 171–175. 29 indexed citations

Anttila, Leena, Gloria Bachmann, L. Hernádi, et al.. (2011). Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies. European Journal of Obstetrics & Gynecology and Reproductive Biology. 155(2). 180–182. 9 indexed citations

10.

Marr, Joachim, Minoo Niknian, L.P. Shulman, & R. Lynen. (2010). Premenstrual dysphoric disorder symptom cluster improvement by cycle with the combined oral contraceptive ethinylestradiol 20 mcg plus drospirenone 3 mg administered in a 24/4 regimen. Contraception. 84(1). 81–86. 25 indexed citations

11.

Strowitzki, T., Joachim Marr, Christoph Gerlinger, Thomas Faustmann, & Christian Seitz. (2010). Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reproduction. 25(3). 633–641. 263 indexed citations

12.

Hernádi, L., Joachim Marr, Dietmar Trummer, Vincenzo De Leo, & Felice Petraglia. (2009). Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. Contraception. 80(1). 18–24. 23 indexed citations

13.

Anttila, Leena, Michael Kunz, & Joachim Marr. (2009). Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Contraception. 80(5). 445–451. 24 indexed citations

14.

Marr, Joachim, Klaas Heinemann, & Michael Kunz. (2009). P723 Ethinylestradiol 20 mcg/drospirenone 3 mg combined oral contraceptive administered in a 24/4 regimen in the treatment of premenstrual dysphoric disorder‐related symptoms and functional impairment: a randomized, multicenter, double‐blind, parallel study. International Journal of Gynecology & Obstetrics. 107(S2). 2 indexed citations

15.

Klipping, Christine, Ingrid Duijkers, Dietmar Trummer, & Joachim Marr. (2008). Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception. 78(1). 16–25. 81 indexed citations

16.

Koltun, William, Anne W. Lucky, Diane Thiboutot, et al.. (2008). Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception. 77(4). 249–256. 69 indexed citations

17.

Cibula, David, et al.. (2006). Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20??g and Drospirenone 3mg. Clinical Drug Investigation. 26(3). 143–150. 16 indexed citations

18.

Gruber, Doris, et al.. (2006). A Comparison of the Cycle Control, Safety, and Efficacy Profile of a 21-Day Regimen of Ethinylestradiol 20??g and Drospirenone 3mg with a 21-Day Regimen of Ethinylestradiol 20??g and Desogestrel??150??g. PubMed. 5(2). 115–121. 19 indexed citations

19.

Klipping, Christine & Joachim Marr. (2005). Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism. Contraception. 71(6). 409–416. 78 indexed citations

20.

Mostow, Steven R., et al.. (1988). Suppression of recurrent genital herpes by single daily dosages of acyclovir.. PubMed. 85(2A). 30–3. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact